Details for New Drug Application (NDA): 217934
✉ Email this page to a colleague
The generic ingredient in BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is brimonidine tartrate; timolol maleate. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the brimonidine tartrate; timolol maleate profile page.
Summary for 217934
| Tradename: | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE |
| Applicant: | Saba Ilac Sanayive |
| Ingredient: | brimonidine tartrate; timolol maleate |
| Patents: | 0 |
Pharmacology for NDA: 217934
| Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Antagonists |
Suppliers and Packaging for NDA: 217934
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217934 | ANDA | Devatis Inc. | 73043-029 | 73043-029-01 | 1 BOTTLE, DROPPER in 1 CARTON (73043-029-01) / 5 mL in 1 BOTTLE, DROPPER |
| BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217934 | ANDA | Devatis Inc. | 73043-029 | 73043-029-02 | 1 BOTTLE, DROPPER in 1 CARTON (73043-029-02) / 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.2%;EQ 0.5% BASE | ||||
| Approval Date: | Jul 1, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
